/
/
/

Sanofi Consumer Healthcare India Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
---21%
---33%
----21%
81%81%81%73%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
MANKIND
DRREDDY
AUROPHARMA
LUPIN
SANOFICONR
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,849.9₹447476 Cr3712.0762.82₹11479 Cr
9,602₹254764 Cr87.134.04128.41₹2568 Cr
4,928.5₹189423 Cr86.8516.7297.06₹2163 Cr
1,180.3₹116658 Cr25.859.4262.53₹5040 Cr
1,399₹111484 Cr33.089.7757.87₹3879 Cr
2,026.2₹109943 Cr100.556.829.25₹889 Cr
2,500₹101712 Cr49.7913.7571.08₹1913 Cr
1,200.4₹101005 Cr31.355.3263.99₹4196 Cr
1,716₹99253 Cr26.7317.9596.84₹3505 Cr
2,100.7₹96031 Cr17.3730.95154.35₹5333 Cr
3,980₹9226 Cr34.6829.91121.23₹240 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%

Balance Sheet

Consolidated
Standalone
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Dec 2025Dec 2024Dec 2023
₹23 Cr₹23 Cr₹2 Cr
₹0₹1 Cr₹23 Cr
₹361 Cr₹249 Cr₹183 Cr
₹361 Cr₹249 Cr₹183 Cr
₹384 Cr₹273 Cr₹208 Cr
-₹9 Cr-₹6 Cr-₹2 Cr
₹17 Cr₹17 Cr₹0
₹221 Cr₹11 Cr₹8 Cr
₹230 Cr₹22 Cr₹6 Cr
₹80 Cr₹70 Cr₹60 Cr
₹13 Cr₹18 Cr₹0
₹36 Cr₹164 Cr₹70 Cr
₹128 Cr₹252 Cr₹130 Cr
₹742 Cr₹547 Cr₹344 Cr
₹2 Cr₹60 L₹0
₹58 Cr₹40 Cr₹11 Cr
₹23 Cr₹11 Cr₹6 Cr
₹36 Cr₹29 Cr₹5 Cr
₹0₹70 L₹0
₹211 Cr₹2 Cr₹0
₹70 L₹1 Cr₹80 L
₹248 Cr₹33 Cr₹8 Cr
₹62 Cr₹41 Cr₹97 Cr
₹30 Cr₹14 Cr₹32 Cr
₹375 Cr₹327 Cr₹2 Cr
₹3 Cr₹6 Cr₹205 Cr
₹25 Cr₹126 Cr₹60 L
₹494 Cr₹513 Cr₹335 Cr
₹366 Cr₹261 Cr₹205 Cr
₹742 Cr₹547 Cr₹344 Cr
₹167₹118₹923
₹167₹118₹923

Cash Flow

Consolidated
Standalone
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Dec 2025Dec 2024Dec 2023
₹320 Cr₹247 Cr₹219 Cr
-₹4 Cr₹50 L-₹2 Cr
-₹54 Cr₹316 Cr-₹213 Cr
₹262 Cr₹563 Cr₹4 Cr
₹175 Cr₹439 Cr-₹40 L
₹8 Cr₹2 Cr₹0
-₹135 Cr-₹116 Cr₹2 Cr
₹48 Cr₹325 Cr₹2 Cr
₹327 Cr₹2 Cr₹0
₹375 Cr₹327 Cr₹2 Cr

Fundamental Ratios

Consolidated
Standalone

Share Price Live Stats

Open (₹)3,999.00
Volume (₹)4,134.00
High (₹)4,068.40
Upper Circuit4,806.40
Low (₹)3,955.00
Lower Circuit3,204.40
Prev Close4,005.40
52W High (₹)5,255.00
Price3,980.00
52W Low (₹)3,926.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)9226.18 Cr
Div. Yield (%)1.87
PE Ratio34.68
Debt to Equity0.00
Price to Book27.11
Book Value166.96
EPS (TTM)115.50
Face Value10.00
ROE (%)73.20

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
SANOFICONRNSE
LTP
1W Low
1W High
Market cap (₹)
1849.9+12.6 (0.69%)
1832.20
1891.50
4,47,476Cr
9602+227 (2.42%)
9312.50
9740
2,54,764Cr
4928.5+88.5 (1.83%)
4848.50
5010
1,89,423Cr
1180.3+20.3 (1.75%)
1152.10
1190.60
1,16,658Cr
1399+4.5 (0.32%)
1364.50
1419
1,11,484Cr
2026.2+72.2 (3.69%)
1963.80
2055.30
1,09,943Cr
2500+199.3 (8.66%)
2303
2504.30
1,01,712Cr
1200.4+15.4 (1.30%)
1185
1222
1,01,005Cr
1716-18 (-1.04%)
1689.30
1740
99,253Cr
2100.7+17.7 (0.85%)
2080
2135
96,031Cr
3980-53.4 (-1.32%)
3955
4081
9,226Cr

Sanofi Consumer Healthcare India Ltd Annual Results Key Takeaways

Basis: Consolidated annual results.

Sanofi Consumer Healthcare India Ltd Quaterly Results Key Takeaways